Accelerating science discovery in food and health using Artificial Intelligence
US-based PIPA LLC has entered into a multi-year agreement with Mars, Incorporated to accelerate the discovery of new plant-based ingredients.
PIPA’s Artificial Intelligence (AI) platform, LEAP, will leverage biomedical databases and innovation pipelines to provide Mars with unique capabilities for designing new products to address growing consumer demand for health benefits from foods, beverages and dietary supplements.
Mars Associates will have the opportunity to use LEAP, thereby accelerating discovery compared with traditional ingredient-identification methods of randomized, high-throughput screening.
LEAP combines state-of-the-art AI and bioinformatics to integrate biomedical databases, scientific publications, clinical trial and omics datasets to highlight associations among molecular and food-related entities with microbes and diseases. This helps predict connections that can accelerate new product development.
PIPA and MARI will roll out LEAP to science, technology and innovation teams at Mars over the next two years.